195 related articles for article (PubMed ID: 8641362)
1. The sensitivity of in vitro erythropoietic progenitor cells to different erythropoietin reagents during development and the role of cell death in culture.
Zimmermann F; Rich IN
Exp Hematol; 1996 Feb; 24(2):330-9. PubMed ID: 8641362
[TBL] [Abstract][Full Text] [Related]
2. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
3. Residual erythroid progenitors in W/W mice respond to erythropoietin in the absence of steel factor signals.
Pharr PN; Hofbauer A; Worthington RE; Longmore GD
Int J Hematol; 2000 Aug; 72(2):178-85. PubMed ID: 11039666
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness to recombinant human erythropoietin (rh-Epo) of marrow erythroid progenitors (CFU-E and BFU-E) from B-chronic lymphocytic leukemia (B-CLL).
Tsatalas C; Chalkia P; Tsantali C; Kakoulidis I; Garyfallos A; Klonizakis I; Panayiotopoulos S
J Exp Clin Cancer Res; 1997 Jun; 16(2):163-70. PubMed ID: 9261742
[TBL] [Abstract][Full Text] [Related]
5. [Comparative analysis of the effects of the unpurified preparations of murine erythropoietin and human recombinant erythropoietin on erythroid and granulocyte-macrophage progenitor cells in semi-solid mouse bone marrow cultures].
Manakova TE; Kapina MA
Biull Eksp Biol Med; 1991 Aug; 112(8):176-9. PubMed ID: 1786383
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
Malgor LA; Valsecia M; Vergés E; De Markowsky EE
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
[TBL] [Abstract][Full Text] [Related]
7. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).
Johnson CS; Cook CA; Furmanski P
Exp Hematol; 1990 Feb; 18(2):109-13. PubMed ID: 2303102
[TBL] [Abstract][Full Text] [Related]
8. The ontogeny of erythropoiesis in the mouse detected by the erythroid colony-forming technique. II. Transition in erythropoietin sensitivity during development.
Rich IN; Kubanek B
J Embryol Exp Morphol; 1980 Aug; 58():143-55. PubMed ID: 7441150
[TBL] [Abstract][Full Text] [Related]
9. EPO receptor, Bax and Bcl-x(L) expressions in murine erythropoiesis after cyclophosphamide treatment.
Juaristi JA; Aguirre MV; Todaro JS; Alvarez MA; Brandan NC
Toxicology; 2007 Mar; 231(2-3):188-99. PubMed ID: 17254689
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic options of erythropoietin-stimulated erythropoiesis.
Nijhof W; de Haan G; Pietens J; Dontje B
Exp Hematol; 1995 Apr; 23(4):369-75. PubMed ID: 7895784
[TBL] [Abstract][Full Text] [Related]
11. Impaired response of polycythemic mice to erythropoietin induced by protein starvation imposed after hormone administration.
Barceló AC; Alippi RM; Boyer P; Olivera MI; Mide SM; Caro J; Bozzini CE
Stem Cells; 1993 Jul; 11(4):296-302. PubMed ID: 8401252
[TBL] [Abstract][Full Text] [Related]
12. Protection of zidovudine-induced toxicity against murine erythroid progenitor cells by vitamin E.
Gogu SR; Lertora JJ; George WJ; Hyslop NE; Agrawal KC
Exp Hematol; 1991 Aug; 19(7):649-52. PubMed ID: 1893952
[TBL] [Abstract][Full Text] [Related]
13. Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agents.
Takatsuki F; Miyasaka Y; Kikuchi T; Suzuki M; Hamuro J
Exp Hematol; 1996 Feb; 24(3):416-22. PubMed ID: 8599970
[TBL] [Abstract][Full Text] [Related]
14. Pure erythropoietic colony and burst formations in serum-free culture and their enhancement by insulin-like growth factor I.
Akahane K; Tojo A; Urabe A; Takaku F
Exp Hematol; 1987 Aug; 15(7):797-802. PubMed ID: 3609183
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory action of aluminum on mouse bone marrow cell growth: evidence for an erythropoietin- and transferrin-mediated mechanism.
Garbossa G; Gutnisky A; Nesse A
Miner Electrolyte Metab; 1994; 20(3):141-6. PubMed ID: 7816003
[TBL] [Abstract][Full Text] [Related]
16. The role of the blood island during normal and 5-fluorouracil-perturbed hemopoiesis.
Vogt C; Noé G; Rich IN
Blood Cells; 1991; 17(1):105-21; discussion 121-5. PubMed ID: 2018848
[TBL] [Abstract][Full Text] [Related]
17. The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates.
Liang DC; Shih LY; Kuo MC; Chai IJ; Su TH; Chen SH; Liu HC; Shimosaka A
Pediatr Hematol Oncol; 2001 Sep; 18(6):383-91. PubMed ID: 11554233
[TBL] [Abstract][Full Text] [Related]
18. The in vitro erythropoietin sensitivity of late erythroid progenitors subjected to opposing physiologic demands.
Monette FC; Ouellette PL; Thorson JA; Hausdorff W; Weiner EJ; Jarris RF
Exp Hematol; 1980 Aug; 8(7):947-53. PubMed ID: 16398028
[TBL] [Abstract][Full Text] [Related]
19. Interleukine-17-induced inhibitory effect on late stage murine erythroid bone marrow progenitors.
Bugarski D; Krstić A; Vlaski M; Petakov M; Jovcić G; Stojanović N; Milenković P
Eur Cytokine Netw; 2004; 15(3):247-54. PubMed ID: 15542450
[TBL] [Abstract][Full Text] [Related]
20. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
